Contreras Jaime 4

4 · ABBOTT LABORATORIES · Filed Apr 23, 2020

Form 4

Period: 2020-04-21

Senior Vice President

Transactions

Exercise/Conversion
Option (right to buy)
2020-04-21−36,715→ 36,715 total
Exercise: $59.94From: 2020-02-16Exp: 2028-02-15→ Common shares (36,715 underlying)
Exercise/Conversion
Common shares without par value
2020-04-21$59.94/sh+36,715$2,200,697→ 119,750 total
Tax Payment
Common shares without par value
2020-04-21$98.00/sh−83,226$8,156,148→ 62,205 total
Exercise/Conversion
Common shares without par value
2020-04-21$75.90/sh+25,681$1,949,188→ 145,431 total
Exercise/Conversion
Option (right to buy)
2020-04-21−46,016→ 0 total
Exercise: $44.40From: 2020-02-17Exp: 2027-02-16→ Common shares (46,016 underlying)
Exercise/Conversion
Option (right to buy)
2020-04-21−25,681→ 51,364 total
Exercise: $75.90From: 2020-02-22Exp: 2029-02-21→ Common shares (25,681 underlying)
Exercise/Conversion
Common shares without par value
2020-04-21$44.40/sh+46,016$2,043,110→ 83,035 total

Holdings

Footnotes (6)

[F1]Balance in the Abbott Laboratories Stock Retirement Trust as of April 21, 2020.
[F2]Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
[F3]The reporting person disclaims beneficial ownership of all securities held by his spouse.
[F4]Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.
[F5]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
[F6]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Documents

1 file